In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan.

Nature aging 2022 May

filter terms:

The FOXM1 transcription factor exhibits pleiotropic C-terminal transcriptional and N-terminal non-transcriptional functions in various biological processes critical for cellular homeostasis. We previously found that FOXM1 repression during cellular aging underlies the senescence phenotypes, which were vastly restored by overexpressing transcriptionally active FOXM1. Yet, it remains unknown whether increased expression of FOXM1 can delay organismal aging. Here, we show that in vivo cyclic induction of an N-terminal truncated FOXM1 transgene on progeroid and naturally aged mice offsets aging-associated repression of full-length endogenous Foxm1, reinstating both transcriptional and non-transcriptional functions. This translated into mitigation of several cellular aging hallmarks, as well as molecular and histopathological progeroid features of the short-lived Hutchison-Gilford progeria mouse model, significantly extending its lifespan. FOXM1 transgene induction also reinstated endogenous Foxm1 levels in naturally aged mice, delaying aging phenotypes while extending their lifespan. Thus, we disclose that FOXM1 genetic rewiring can delay senescence-associated progeroid and natural aging pathologies. © 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Citation

Rui Ribeiro, Joana C Macedo, Madalena Costa, Vladimir Ustiyan, Anastasia V Shindyapina, Alexander Tyshkovskiy, Rita N Gomes, José Pedro Castro, Tanya V Kalin, Francisco Vasques-Nóvoa, Diana S Nascimento, Sergey E Dmitriev, Vadim N Gladyshev, Vladimir V Kalinichenko, Elsa Logarinho. In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging. 2022 May;2(5):397-411